Protein Klotho and FGF23 fibroblasts growth factor as markers of chronic renal disease
Chronic kidney disease (CKD) is a global public health problem in the world. Research scientists are aimed at finding new biomarkers for CKD. Such biomarkers are α-Klotho soluble protein and fibroblast growth factor (FGF23). It was shown that the expression of Klotho protein decreases progressively...
Main Author: | A.A. Melnik |
---|---|
Format: | Article |
Language: | English |
Published: |
Publishing House Zaslavsky
2017-08-01
|
Series: | Počki |
Subjects: | |
Online Access: | http://kidneys.zaslavsky.com.ua/article/view/109027 |
Similar Items
-
Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications
by: Laura Salanova Villanueva, et al.
Published: (2016-07-01) -
FGF23 Actions on Target Tissues—With and Without Klotho
by: Beatrice Richter, et al.
Published: (2018-05-01) -
Skeletal manifestations in end-stage renal disease patients and relation to FGF23 and Klotho
by: TOMŞA Anamaria Magdalena, et al.
Published: (2020-09-01) -
Osteocytic FGF23 and Its Kidney Function
by: Rafiou Agoro, et al.
Published: (2020-08-01) -
Serum Klotho in Living Kidney Donors and Kidney Transplant Recipients: A Meta-Analysis
by: Charat Thongprayoon, et al.
Published: (2020-06-01)